751611118	751611118	CD	B-NP	O
|	|	NN	I-NP	O
BMH	BMH	NN	I-NP	O
|	|	NN	I-NP	O
51425337	51425337	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9999910	9999910	CD	B-NP	O
|	|	CC	I-NP	O
4/2/2005	4/2/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
chronic	chronic	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/7/2005	4/7/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/7/2005	11/7/2005	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
KS	KS	NN	B-NP	O
416-43-23-8	416-43-23-8	CD	I-NP	O
Georgia	Georgia	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
1/22/05	1/22/05	CD	B-NP	O
AT	AT	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
WAGUESPACK	WAGUESPACK	NNP	B-NP	O
,	,	,	O	O
DOUGLAS	DOUGLAS	NNP	B-NP	O
IRVING	IRVING	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
LASIX	LASIX	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
600	600	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
HYDRALAZINE	HYDRALAZINE	NN	I-NP	B-protein
HCL	HCL	NN	I-NP	I-protein
25	25	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Take	Take	VB	B-VP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

ISORDIL	ISORDIL	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
DINITRATE	DINITRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
60	60	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
METHADONE	METHADONE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
oversedation	oversedation	NN	B-NP	O
,	,	,	O	O
rr	rr	NN	B-NP	B-protein
<	<	SYM	B-NP	I-protein
10	10	CD	I-NP	I-protein
LOPRESSOR	LOPRESSOR	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
METOPROLOL	METOPROLOL	NN	I-NP	I-protein
TARTRATE	TARTRATE	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
50	50	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	B-NP	O
100	100	CD	I-NP	O
and	and	CC	I-NP	O
hr	hr	NN	I-NP	O
<	<	SYM	I-NP	O
45	45	CD	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

TEGRETOL	TEGRETOL	NN	B-NP	O
XR	XR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CARBAMAZEPINE	CARBAMAZEPINE	NN	I-NP	O
EXTENDED	EXTENDED	VBD	B-VP	O
RELEASE	RELEASE	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
PRILOSEC	PRILOSEC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OMEPRAZOLE	OMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
ALLOPURINOL	ALLOPURINOL	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QOD	QOD	NN	I-NP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	I-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/22/05	1/22/05	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
84710989	84710989	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
NSAIDs	NSAID	NNS	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Unknown	Unknown	JJ	B-ADJP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
takes	take	NNS	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	I-NP	O
NAS	NAS	NN	I-NP	B-protein
/	/	SYM	B-VP	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/day	cals/day	NN	I-NP	O
/	/	SYM	B-NP	O
Low	Low	NN	I-NP	O
saturated	saturate	VBD	B-VP	O
fat	fat	JJ	B-NP	O
low	low	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
FHAH	FHAH	NNP	B-NP	O
Cardiology	Cardiology	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
scheduled	schedule	VBN	I-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NSAIDs	NSAID	NNS	B-NP	O
,	,	,	O	O
TICLOPIDINE	TICLOPIDINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
chronic	chronic	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CAD	CAD	NNP	I-NP	O
,	,	,	O	O
S/P	S/P	NNP	B-NP	O
CABG	CABG	NNP	I-NP	O
S/P	S/P	NN	I-NP	O
PTCA	PTCA	NN	I-NP	O
GOUT	GOUT	NN	I-NP	O
PROTEINURIA	PROTEINURIA	NN	I-NP	O
CRI	CRI	NN	I-NP	O
hypertriglyceridemia	hypertriglyceridemia	NN	I-NP	O
htn	htn	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ETT	ETT	NNP	I-NP	O
MIBI	MIBI	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
r/o	r/o	NN	B-NP	O
MI	MI	NNP	I-NP	O
HPI	HPI	NNP	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
59	59	CD	I-NP	O
yo	yo	NN	I-NP	O
m	m	NN	I-NP	O
with	with	IN	B-PP	O
CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
2v	2v	NN	I-NP	O
cabg	cabg	NN	I-NP	O
1998	1998	CD	B-NP	O
and	and	CC	O	O
multiple	multiple	JJ	B-NP	O
PCI	PCI	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
hyperchol	hyperchol	NN	B-NP	O
,	,	,	O	O
T2DM	T2DM	NN	B-NP	O
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
3	3	CD	B-NP	O
wks	wk	NNS	I-NP	O
of	of	IN	B-PP	O
CP/diaphoresis/n	CP/diaphoresis/n	NN	B-NP	B-protein
/	/	SYM	B-NP	O
v	v	NN	I-NP	O
/	/	SYM	B-NP	O
SOB	SOB	NN	I-NP	B-protein
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
many	many	JJ	B-NP	O
SLNT	SLNT	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
reportschest	reportschest	NN	I-NP	O
pain	pain	NN	I-NP	O
chronically	chronically	RB	B-ADVP	O
with	with	IN	B-PP	O
exertion	exertion	NN	B-NP	O
after	after	IN	B-PP	O
walking	walk	VBG	B-VP	O
about	about	IN	B-NP	O
3	3	CD	I-NP	O
blocks	block	NNS	I-NP	O
since	since	IN	B-PP	O
cath	cath	NN	B-NP	O
2001	2001	CD	I-NP	O
.	.	.	O	O

ROS	ROS	NN	B-NP	O
also	also	RB	B-ADVP	O
+	+	SYM	B-NP	O
for	for	IN	B-PP	O
30	30	CD	B-NP	O
lb	lb	NN	I-NP	O
weight	weight	NN	I-NP	O
loss	loss	NN	I-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
decreased	decrease	VBN	B-NP	O
appetite	appetite	NN	I-NP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
peripheral	peripheral	JJ	B-NP	O
neuropathy	neuropathy	NN	I-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
hyperchol	hyperchol	NN	B-NP	O
diet	diet	NN	I-NP	O
controlled	control	VBD	B-VP	O
DM	DM	NN	B-NP	O
,	,	,	O	O
CCY	CCY	NN	B-NP	O
,	,	,	O	O
EtOH	EtOH	NN	B-NP	O
abuse	abuse	NN	I-NP	O
.	.	.	O	O

VS	VS	NNS	B-NP	O
96.1	96.1	CD	B-NP	O
43173/79	43173/79	CD	I-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
T	T	NN	B-NP	O
97.2	97.2	CD	I-NP	O
P	P	NN	I-NP	O
54	54	CD	B-NP	O
BP	BP	NN	I-NP	O
158/71	158/71	CD	B-NP	O
O2	O2	NN	I-NP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
2L	2L	NN	I-NP	O
NAD	NAD	NN	I-NP	O
,	,	,	O	O
resting	rest	VBG	B-VP	O
horizontal	horizontal	JJ	B-NP	O
nystagmus	nystagmus	NN	I-NP	O
,	,	,	O	O
neuro	neuro	NN	B-NP	O
exam	exam	NN	I-NP	O
o/w	o/w	NN	I-NP	O
nonfocal	nonfocal	JJ	B-ADJP	O
,	,	,	O	O
neck	neck	NN	B-NP	O
supple	supple	NN	I-NP	O
,	,	,	O	O
jvp	jvp	NN	B-NP	B-protein
7	7	CD	I-NP	I-protein
,	,	,	O	O
lungs	lung	VBZ	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	I-NP	O
L	L	NN	I-NP	O
base	base	NN	I-NP	O
crackles	crackle	NNS	I-NP	O
,	,	,	O	O
?	?	.	O	O

S4S1S2	S4S1S2	NN	B-NP	O
50s	50	NNS	I-NP	O
,	,	,	O	O
abdomen	abdomen	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
mild	mild	JJ	I-NP	O
LLQ	LLQ	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
,	,	,	O	O
ext	ext	JJ	B-NP	O
wwp	wwp	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
trace	trace	NN	I-NP	B-protein
edema	edema	NN	I-NP	I-protein
over	over	IN	B-PP	I-protein
shins	shin	NNS	B-NP	I-protein
ADMISSION	ADMISSION	NN	I-NP	I-protein
LABS	LABS	NN	I-NP	I-protein
:	:	:	O	O
WBC	WBC	NN	B-NP	B-DNA
5.18	5.18	CD	I-NP	I-DNA
,	,	,	O	O
HCt	HCt	NN	B-NP	B-protein
40.1	40.1	CD	I-NP	I-protein
,	,	,	O	O
Plt	Plt	NNP	B-NP	O
141	141	CD	I-NP	O
K	K	NN	I-NP	O
5.6	5.6	CD	I-NP	O
,	,	,	O	O
Cr	Cr	NNP	B-NP	O
2.4	2.4	CD	I-NP	O
,	,	,	O	O
BNP	BNP	NN	B-NP	B-protein
103	103	CD	I-NP	I-protein
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	O
markers	marker	NNS	I-NP	O
flat	flat	JJ	B-NP	O
x	x	NN	I-NP	O
1	1	CD	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
sinus	sinus	NN	B-NP	O
brady	brady	NN	I-NP	O
,	,	,	O	O
1st	1st	JJ	B-NP	O
avb	avb	NN	I-NP	O
,	,	,	O	O
nl	nl	NN	B-NP	O
axis	axis	NN	I-NP	O
,	,	,	O	O
QTC	QTC	NN	B-NP	B-DNA
426	426	CD	I-NP	I-DNA
,	,	,	O	O
TW	TW	NNP	B-NP	O
flat	flat	NN	I-NP	O
III	III	CD	I-NP	O
+	+	SYM	I-NP	O
AVF	AVF	NN	I-NP	B-protein
,	,	,	O	O
1/2	1/2	CD	B-NP	O
mm	mm	NN	I-NP	O
STD	STD	NN	I-NP	O
I	I	NN	I-NP	O
,	,	,	O	O
avL	avL	NN	B-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
CXR	CXR	NN	I-NP	O
:	:	:	O	O
borderline	borderline	JJ	B-NP	O
cardiomeg	cardiomeg	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
cp	cp	NN	I-NP	O
process	process	NN	I-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
59	59	CD	B-NP	O
yo	yo	NN	I-NP	O
man	man	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
extensive	extensive	JJ	I-NP	O
hx	hx	NN	I-NP	O
CAD	CAD	NN	I-NP	O
p/w	p/w	NN	I-NP	O
3	3	CD	B-NP	O
wks	wk	NNS	I-NP	O
crescendo	crescendo	VBP	B-VP	O
angina	angina	NN	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
non-specific	non-specific	JJ	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
markers	marker	NNS	I-NP	O
neg	neg	NN	I-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
i	i	AFX	O	O
-	-	HYPH	O	O
*	*	SYM	B-NP	O
known	know	VBN	B-VP	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
crescendo	crescendo	NN	B-NP	O
angina	angina	NN	I-NP	O
,	,	,	O	O
EKG	EKG	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
non-specific	non-specific	JJ	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
card	card	NN	B-NP	B-protein
markers	marker	NNS	I-NP	I-protein
neg	neg	NN	I-NP	I-protein
x	x	SYM	O	I-protein
3	3	CD	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

ROMI	ROMI	NN	B-NP	O
neg	neg	NN	I-NP	O
,	,	,	O	O
ECHO	ECHO	NN	B-NP	O
final	final	JJ	I-NP	O
report	report	NN	I-NP	O
pending	pende	VBG	B-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
but	but	CC	O	O
prelim	prelim	VBP	B-VP	O
read	read	VBN	I-VP	O
with	with	IN	B-PP	O
EF	EF	NN	B-NP	O
65	65	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
RWMA	RWMA	NN	I-NP	B-protein
,	,	,	O	O
tr	tr	NN	B-NP	B-protein
MR	MR	NN	I-NP	I-protein
,	,	,	O	O
LAE	LAE	NN	B-NP	B-protein
,	,	,	O	O
mild	mild	JJ	B-NP	O
LVH	LVH	NN	I-NP	O
.	.	.	O	O

ETT	ETT	NN	B-NP	O
MIBI	MIBI	NN	I-NP	O
with	with	IN	B-PP	O
area	area	NN	B-NP	O
of	of	IN	B-PP	O
mild	mild	JJ	B-NP	O
reversible	reversible	JJ	I-NP	O
defect	defect	NN	I-NP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-NP	O
MIBI	MIBI	NNP	I-NP	O
in	in	IN	B-PP	O
2003	2003	CD	B-NP	O
;	;	:	O	O
rec	rec	NN	B-NP	O
continued	continue	VBD	B-VP	O
medical	medical	JJ	B-NP	O
management	management	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
prior	prior	JJ	I-NP	O
cath	cath	NN	I-NP	O
with	with	IN	B-PP	O
PDA	PDA	NN	B-NP	B-protein
filled	fill	VBN	B-VP	O
by	by	IN	B-PP	O
right	right	JJ	B-NP	O
collateral	collateral	NN	I-NP	O
with	with	IN	B-PP	O
atretic	atretic	JJ	B-NP	O
RIMA	RIMA	NN	I-NP	O
to	to	TO	B-PP	O
RCA	RCA	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Given	Give	VBN	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
renal	renal	JJ	B-NP	O
damange	damange	NN	I-NP	O
with	with	IN	B-PP	O
cath	cath	NN	B-NP	O
and	and	CC	O	O
unclear	unclear	JJ	B-NP	O
benefit	benefit	NN	I-NP	O
of	of	IN	B-PP	O
distal	distal	JJ	B-NP	O
territory	territory	JJ	I-NP	O
revasc	revasc	NN	I-NP	O
deferred	defer	VBD	B-VP	O
cath	cath	NN	B-NP	O
for	for	IN	B-PP	O
now	now	RB	B-NP	O
and	and	CC	O	O
opting	opte	VBG	B-VP	O
for	for	IN	B-PP	O
medical	medical	JJ	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

Rx	Rx	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-VP	O
asa	asa	NN	B-NP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	B-protein
x	x	NN	I-NP	I-protein
36hrs	36hr	NNS	I-NP	I-protein
,	,	,	O	O
isordil	isordil	NN	B-NP	O
.	.	.	O	O

Continued	Continue	VBN	B-VP	O
on	on	IN	B-PP	O
beta	beta	NN	B-NP	O
blocker	blocker	NN	I-NP	O
and	and	CC	I-NP	O
hydralazine	hydralazine	NN	I-NP	O
for	for	IN	B-PP	O
BP	BP	NN	B-NP	O
control	control	NN	I-NP	O
;	;	:	O	O
would	would	MD	B-VP	O
resumre	resumre	VB	I-VP	O
ACE	ACE	NN	B-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
if	if	IN	B-SBAR	O
renal	renal	JJ	B-NP	O
function	function	NN	I-NP	O
remains	remain	VBZ	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

Consider	Consider	VB	B-VP	O
peripheral	peripheral	JJ	B-NP	O
vasodilator	vasodilator	NN	I-NP	O
if	if	IN	B-SBAR	O
htn	htn	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
hydral	hydral	JJ	I-NP	O
added	add	VBN	I-NP	O
p	p	NN	I-NP	O
-	-	HYPH	O	O
*	*	SYM	B-NP	B-protein
HTN	HTN	NN	I-NP	I-protein
*	*	SYM	B-NP	O
See	See	NN	I-NP	B-protein
above	above	RB	B-ADVP	O
.	.	.	O	O

*	*	SYM	O	O
euvolemic	euvolemic	JJ	B-NP	O
*	*	SYM	I-NP	O
briefly	briefly	NN	I-NP	O
had	have	VBD	B-VP	O
sinus	sinus	NN	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
to	to	TO	B-PP	O
40s	40s	CD	B-NP	O
overnight	overnight	NN	I-NP	O
,	,	,	O	O
daytime	daytime	NN	B-NP	O
HR	HR	NN	I-NP	O
in	in	IN	B-PP	O
70s	70	NNS	B-NP	O
Tele	Tele	NNP	B-NP	O
.	.	.	O	O

Replete	Replete	JJ	B-NP	O
lytes	lyte	NNS	I-NP	O
as	as	IN	B-PP	O
needed	need	VBN	B-NP	O
given	give	VBN	I-NP	O
high	high	JJ	B-NP	O
cr	cr	NN	I-NP	O
.	.	.	O	O

*	*	SYM	O	O
chol	chol	NN	B-NP	O
*	*	SYM	I-NP	O
Rx	Rx	NN	I-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
gemfibrozil	gemfibrozil	NN	I-NP	O
.	.	.	O	O

NEURO	NEURO	NN	B-NP	B-protein
:	:	:	O	O
*	*	SYM	B-NP	O
peripheral	peripheral	JJ	I-NP	O
neuropathy	neuropathy	NN	I-NP	O
*	*	SYM	B-VP	O
Rx	Rx	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
methadone	methadone	NN	I-NP	O
,	,	,	O	O
tegratol	tegratol	NN	B-NP	O
*	*	SYM	I-NP	O
etOH	etOH	NN	I-NP	O
*	*	SYM	B-NP	O
Rx	Rx	NN	I-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
PRN	PRN	NN	I-NP	O
ativan	ativan	NN	I-NP	O
in	in	IN	B-PP	O
case	case	NN	B-NP	O
of	of	IN	B-PP	O
w/d	w/d	NN	B-NP	O
PULM	PULM	NN	I-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
subjective	subjective	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
*	*	SYM	B-NP	O
Ddx	Ddx	NN	I-NP	O
ischemia	ischemia	NN	I-NP	O
,	,	,	O	O
lower	low	JJR	B-NP	O
prob	prob	NN	I-NP	O
PE	PE	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
PNA	PNA	NN	B-NP	B-protein
,	,	,	O	O
edema	edema	NN	B-NP	O
,	,	,	O	O
atelectasis	atelectasis	NN	B-NP	O
.	.	.	O	O

Eval	Eval	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
as	as	IN	B-PP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
PECT	PECT	NN	I-NP	B-protein
given	give	VBN	B-VP	I-protein
lower	low	JJR	B-NP	I-protein
prob	prob	NN	I-NP	I-protein
+	+	CC	O	O
high	high	JJ	B-NP	O
cr	cr	NN	I-NP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
*	*	SYM	B-NP	O
GERD	GERD	NN	I-NP	O
*	*	SYM	B-NP	O
nexium	nexium	NN	I-NP	O
*	*	SYM	I-NP	O
bowel	bowel	NN	I-NP	O
reg	reg	NN	I-NP	O
*	*	SYM	B-NP	O
RENAL	RENAL	NN	I-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
CRI	CRI	NN	I-NP	O
*	*	SYM	B-NP	O
w/in	w/in	NN	I-NP	O
baseline	baseline	NN	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
Cr	Cr	NN	I-NP	O
2.5	2.5	CD	I-NP	O
.	.	.	O	O

*	*	SYM	O	O
hyperk	hyperk	NN	B-NP	O
*	*	SYM	I-NP	O
No	No	NN	I-NP	O
sx	sx	NN	I-NP	O
or	or	CC	I-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Likely	Likely	RB	B-NP	O
2/2	2/2	CD	I-NP	O
CRI	CRI	NN	I-NP	O
.	.	.	O	O

Give	Give	VB	B-VP	O
kayex	kayex	NN	B-NP	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
IV	IV	CD	I-NP	O
x1	x1	NN	I-NP	O
.	.	.	O	O

Recheck	Recheck	NN	B-NP	O
.	.	.	O	O

WNl	WNl	NNP	B-NP	O
ENDO	ENDO	NNP	I-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
DM	DM	NN	I-NP	O
*	*	SYM	B-NP	O
continue	continue	JJ	I-NP	O
diabetic	diabetic	JJ	I-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
ONC	ONC	NN	I-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
weight	weight	NN	I-NP	O
loss	loss	NN	I-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
*	*	SYM	B-NP	O
Check	Check	NNP	I-NP	O
amschi	amschi	NN	I-NP	O
labox	labox	NN	I-NP	O
memorial	memorial	JJ	I-NP	O
medical	medical	JJ	I-NP	O
center	center	NN	I-NP	O
records	record	NNS	I-NP	O
re	re	VBP	B-VP	O
:	:	:	O	O
age-appropriate	age-appropriate	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
screening	screening	NN	I-NP	O
.	.	.	O	O

F.u	F.u	NN	B-NP	O
PSA	PSA	NN	I-NP	O
wnl	wnl	NN	I-NP	O
.	.	.	O	O

PROPH	PROPH	NN	B-NP	O
:	:	:	O	O
heparin/nexium	heparin/nexium	NN	B-NP	O
CODE	CODE	NN	I-NP	O
:	:	:	O	O
full	full	JJ	B-NP	O
ADDITIONAL	ADDITIONAL	JJ	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
SALDANA	SALDANA	NNP	B-NP	O
,	,	,	O	O
DOYLE	DOYLE	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
RE23	RE23	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1/22/05	1/22/05	CD	I-NP	O
@	@	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
29	29	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

